Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

DuPont focuses on development of MMP inhibitors selective for TNF production

Dec. 15, 1999

Hoechst DMARD now in U.K. pharmacies

Dec. 15, 1999

Cypress Bioscience and Medexus enter agreement for Prosorba Column in Canada

Dec. 13, 1999

Potent and selective caspase 1 (ICE) inhibitors codeveloped at Warner-Lambert and BASF

Dec. 10, 1999

COX-2 inhibitors: pros and cons debated in current literature

Dec. 7, 1999

p38 MAP kinase inhibitors described by Roche for inflammatory disorders

Dec. 6, 1999

Promising results seen in phase II/III lupus clinical trial

Dec. 3, 1999

First murine (and human) CCR1 receptor antagonist reported by Banyu at Japanese meeting

Dec. 2, 1999

6-Nitroquinazolines with dual TNF-alpha production/T-cell proliferation-suppressive effects

Dec. 2, 1999

Fused thiophenes from Ono inhibit IL-6 and/or IL-12 production

Dec. 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...